MycoDART
MycoDART, Inc. specializes in cutting-edge PCR technology for rapid and accurate detection of fungal infections such as Candida, Aspergillus, and Mucor. Their patented DNA probes enable species identification within 4-6 hours, significantly reducing diagnosis time compared to traditional blood cultures, thereby facilitating timely and appropriate treatment for at-risk patients.
Industries
MycoDART
Carrollton, Texas, United States, North America
Products
Candida PCR diagnostic panel
Qualitative dual-amplification real-time PCR panel for species-level detection of common Candida spp. from clinical specimens.
Aspergillus PCR diagnostic panel
Qualitative dual-amplification real-time PCR panel for detection and differentiation of common Aspergillus species from clinical specimens.
Mucor PCR diagnostic panel
Qualitative dual-amplification real-time PCR assay for detection of Mucor spp. from clinical specimens.
Candida PCR diagnostic panel
Qualitative dual-amplification real-time PCR panel for species-level detection of common Candida spp. from clinical specimens.
Aspergillus PCR diagnostic panel
Qualitative dual-amplification real-time PCR panel for detection and differentiation of common Aspergillus species from clinical specimens.
Mucor PCR diagnostic panel
Qualitative dual-amplification real-time PCR assay for detection of Mucor spp. from clinical specimens.
Expertise Areas
- Molecular diagnostics
- Fungal infectious disease diagnostics
- Real-time PCR assay development
- Species-level pathogen identification
Key Technologies
- Real-time quantitative PCR (qPCR)
- Dual-amplification / multiplex PCR
- DNA probe–based detection
- Nucleic-acid detection from blood/plasma/BAL